BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17369830)

  • 21. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
    Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
    Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours.
    Scotton C; Milliken D; Wilson J; Raju S; Balkwill F
    Br J Cancer; 2001 Sep; 85(6):891-7. PubMed ID: 11556842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
    Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
    Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards invasive phenotype.
    Sato Y; Higuchi T; Yoshioka S; Tatsumi K; Fujiwara H; Fujii S
    Development; 2003 Nov; 130(22):5519-32. PubMed ID: 14530297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory Molecule,
    Li J; Zhou Z; Zhang X; Zheng L; He D; Ye Y; Zhang QQ; Qi CL; He XD; Yu C; Shao CK; Qiao L; Wang L
    Mol Cancer Res; 2017 Apr; 15(4):467-477. PubMed ID: 28108624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas.
    Lu P; Nakamoto Y; Nemoto-Sasaki Y; Fujii C; Wang H; Hashii M; Ohmoto Y; Kaneko S; Kobayashi K; Mukaida N
    Am J Pathol; 2003 Apr; 162(4):1249-58. PubMed ID: 12651617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
    J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
    Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
    FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
    Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
    Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
    Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
    Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of human LZIP in differential activation of the NF-kappaB pathway that is induced by CCR1-dependent chemokines.
    Jang SW; Kim YS; Lee YH; Ko J
    J Cell Physiol; 2007 Jun; 211(3):630-7. PubMed ID: 17192849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
    Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
    J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
    Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
    Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.